Recent News
On July 2, 2025 the company announced it would report fourth-quarter fiscal 2025 results on July 30, 2025. On July 30, 2025 New Oriental published its fourth-quarter and full-year results for the fiscal year ended May 31, 2025. In late June and July several broker notes revised ratings: JPMorgan upgraded to overweight on June 24–26 timeframe and Citigroup published an upgrade on June 27, 2025; HSBC issued a downgrade on July 30, 2025. In August 2025 Goldman Sachs reduced its rating on August 6, and filings noted block sales and institutional position changes in mid-August.
Technical Analysis
Directional indicators present a bearish tilt: DI+ at 35.75 shows a recent peak-and-reversal, while DI- at 22.93 shows a dip-and-reversal; both patterns indicate directional pressure shifting toward sellers despite a still-elevated DI+ level. ADX at 21.12 signals only emerging trend strength, so directional signals carry limited conviction for sustained moves.
MACD sits at 1.16 just above its signal line at 1.14, but the MACD trend reads as a peak-and-reversal, which indicates waning bullish momentum despite the marginal intraday positioning above the signal line.
MRO registers positive at 6.15 with an increasing trajectory, indicating price sits above the model target and exhibits modest downward pressure as momentum normalizes toward target levels.
RSI at 54.02 with a peak-and-reversal pattern points to a short-term loss of upward momentum while remaining in the neutral band, consistent with consolidation rather than a decisive breakout or breakdown.
Price vs moving averages: the last close at $50.88 trades just below the 20-day average of $52.24 and very near the 200-day average of $50.57; the 12-day EMA shows a peak-and-reversal, reinforcing near-term lateral price action bounded by short-term resistance near the 20-day average and the super-trend upper band at $54.74.
Volatility and volume context compresses the signal: 42-day volatility stands at 2% and 52-week volatility at 3%, while daily volume (554,800) remains below the 10/50/200-day averages, indicating lower participation and increasing probability of range-bound moves until a catalyst restores volume.
Fundamental Analysis
Earnings: Q4 EPS arrived at $0.61 versus an estimate of $0.42, producing an EPS surprise of +45.24%. That beat coincides with a negative annual earnings-growth profile: earnings growth registered -12.86% year-over-year, with QoQ change at -105.89% and YoY at -80.24%, highlighting pronounced recent earnings volatility despite the beat.
Valuation metrics present a disconnect between current and forward expectations. Trailing PE equals 80.66 while forward PE sits at 44.85; forward EPS forecasts $1.08. The trailing PE sits above the industry peer mean of 63.31 and median of 54.73, placing the stock above typical peer multiples. PEG registers -6.27, below the industry peer mean of -1.71 and median of -0.50, with the peer range spanning from -17.59 to 8.39.
Revenue figures show anomalous values: reported revenue growth reads 0.00% overall, with both QoQ and YoY flagged as -100.00% in the provided figures; those metrics indicate an extreme decline in reported growth rates and warrant careful attention to company disclosures and segment reporting for reconciliation.
Balance-sheet and cash metrics: invested capital stands at $-3,556,136,000; reported cash-flow margin and cash-flow-to-earnings are both 0.00 in the provided figures. WMDST values the stock as fair-valued, reflecting the combination of a rich trailing multiple, lower forward multiple, EPS beats alongside sharply negative growth rates, and the apparent cash/ invested-capital profile.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-05-31 |
| REPORT DATE: | 2025-07-30 |
| NEXT REPORT DATE: | 2025-10-28 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 0.42 | |
| EPS Actual | $ 0.61 | |
| EPS Difference | $ 0.19 | |
| EPS Surprise | 45.238 % | |
| Forward EPS | $ 1.08 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 80.66 | |
| Price To Earnings QoQ | 14.921 % | |
| Price To Earnings YoY | -76.945 % | |
| Price To Earnings IPRWA | high: 178.212 EDU: 80.66 mean: 63.308 median: 54.734 low: -169.263 |
|
| PE/G Ratio | -6.274 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 44.852 | |
| Forward PE/G | -3.489 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 157.689 median: 84.876 mean: 60.418 EDU: 0 low: -22.108 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -3.56 B | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.0 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | high: 17.27 % EDU: 0.0 % mean: -1.326 % median: -1.518 % low: -14.452 % |
|
| Earnings Growth | -12.857 % | |
| Earnings Growth QoQ | -105.893 % | |
| Earnings Growth YoY | -80.244 % | |
| Earnings Growth IPRWA | high: 191.304 % EDU: -12.857 % median: -13.542 % mean: -30.546 % low: -300.0 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |